Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SOPH

SOPHiA Genetics SA

Apr 29 • 04:00PM ET

5.28

+0.28 5.60 %

Healthcare • Health Information Services • Switzerland • Small • NASD

Peers: ILMN QGEN GH TXG OMIC CRSP EDIT NTLA DNA PACB

| Held by: ONEQ MEDI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.17	Insider Own	32.86%	Shs Outstand	68.49M	Perf Week	2.92%
Market Cap	378.41M	Forward P/E	-	EPS next Y	-0.67	Insider Trans	-0.84%	Shs Float	48.12M	Perf Month	12.58%
Enterprise Value	371.14M	PEG	-	EPS next Q	-0.23	Inst Own	25.58%	Short Float	0.37%	Perf Quarter	0.57%
Income	-79.00M	P/S	4.90	EPS this Y	26.92%	Inst Trans	0.69%	Short Ratio	1.33	Perf Half Y	25.71%
Sales	77.27M	P/B	7.67	EPS next Y	22.22%	ROA	-49.40%	Short Interest	0.18M	Perf YTD	13.06%
Book/sh	0.69	P/C	5.38	EPS next 5Y	25.95%	ROE	-110.00%	52W High	5.70 -7.37%	Perf Year	67.09%
Cash/sh	0.98	P/FCF	-	EPS past 3/5Y	5.00% -13.68%	ROIC	-73.51%	52W Low	2.59 103.86%	Perf 3Y	9.09%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	17.56% 22.16%	Gross Margin	67.40%	Volatility	5.54% 5.75%	Perf 5Y	-
Dividend TTM	-	EV/Sales	4.80	EPS Y/Y TTM	-23.69%	Oper. Margin	-90.49%	ATR (14)	0.27	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.84	Sales Y/Y TTM	18.56%	Profit Margin	-102.24%	RSI (14)	61.35	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.96	EPS Q/Q	-23.57%	SMA20	5.76%	Beta	0.99	Target Price	8.00
Payout	-	Debt/Eq	1.34	Sales Q/Q	22.41%	SMA50	10.02%	Rel Volume	0.54	Prev Close	5.00
Employees	415	LT Debt/Eq	1.28	Earnings	May 05 BMO	SMA200	20.55%	Avg Volume	132.46K	Price	5.28
IPO	Jul 23, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-17.89% 5.93%	Trades		Volume	71,277	Change	5.60%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-18-24	Initiated	Craig Hallum	Buy	$11
Aug-07-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$10 → $5
Jun-27-24	Initiated	Guggenheim	Buy	$6
Nov-29-23	Initiated	RBC Capital Mkts	Outperform	$8
Jul-05-23	Resumed	JP Morgan	Overweight	$10
Jan-03-23	Initiated	BTIG Research	Buy	$6
Nov-23-22	Initiated	Credit Suisse	Neutral	$2
Oct-15-21	Resumed	Cowen	Outperform
Aug-17-21	Initiated	Morgan Stanley	Overweight	$24
Aug-17-21	Initiated	JP Morgan	Overweight	$23
Aug-17-21	Initiated	Credit Suisse	Outperform	$22
Aug-17-21	Initiated	Cowen	Outperform

Show Previous Ratings

Apr-21-26 08:00AM	SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026 (PR Newswire)
Apr-16-26 08:00AM	Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 (PR Newswire)
Mar-04-26 08:02PM	Sophia Genetics SA (SOPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Mar-03-26 01:30PM	SOPHiA GENETICS Q4 Earnings Call Highlights (MarketBeat) -11.26%
12:34PM	SOPHiA GENETICS S.A. Q4 2025 Earnings Call Summary (Moby)
06:45AM	Loading…
06:45AM	SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results (PR Newswire)
Feb-25-26 08:00AM	SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference (PR Newswire)
Feb-18-26 09:41AM	Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy? (Zacks)
Feb-17-26 08:00AM	SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 (PR Newswire)
Feb-10-26 09:22AM	SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems (PR Newswire)
Jan-12-26 07:00AM	SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan (PR Newswire)
Jan-07-26 08:00AM	SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology (PR Newswire)
Dec-12-25 10:15AM	AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave (PR Newswire)
Nov-25-25 07:46AM	Tempus AI's Data Business Is Expanding and Adding to Revenues: Here's How (Zacks)
Nov-11-25 09:00AM	SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine (PR Newswire) +6.21%
08:01AM	Loading…
08:01AM	SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine (PR Newswire)
Nov-08-25 08:00PM	Sophia Genetics SA (SOPH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... (GuruFocus.com)
Nov-04-25 06:45AM	SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance (PR Newswire) -6.40%
Nov-03-25 08:04AM	Earnings To Watch: Sophia Genetics SA (SOPH) Reports Q3 2025 Result (GuruFocus.com)
Oct-21-25 08:00AM	SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 (PR Newswire)
Oct-20-25 09:03AM	Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy? (Zacks)
Oct-16-25 11:00AM	A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan (PR Newswire)
04:01AM	SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology (PR Newswire)
Sep-23-25 08:01AM	Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy (PR Newswire)
Sep-22-25 08:00AM	SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer (PR Newswire) +18.37%
Sep-08-25 05:36AM	Jessa Ziekenhuis to adopt SOPHiA GENETICS platform for cancer care (Hospital Management)
Sep-05-25 04:00AM	SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology (PR Newswire)
Aug-19-25 09:33AM	Strategic Partnerships Power Tempus AI's Healthcare Expansion (Zacks)
Aug-13-25 03:00PM	Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold? (Zacks)
Aug-06-25 11:01AM	Sophia Genetics SA (SOPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -7.95%
06:45AM	Loading…
Aug-05-25 06:45AM	SOPHiA GENETICS Reports Second Quarter 2025 Results (PR Newswire)
06:40AM	SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes (PR Newswire)
Aug-04-25 10:07AM	Sophia Genetics SA (SOPH) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-01-25 03:00PM	Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy? (Zacks)
Jul-22-25 08:00AM	SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025 (PR Newswire)
Jul-17-25 03:00PM	TEM Shares Surge on New AI Breakthrough: Should Investors Jump In? (Zacks)
Jun-09-25 03:00PM	Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today? (Zacks) -8.63%
May-15-25 03:00PM	After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? (Zacks)
May-07-25 03:06AM	Sophia Genetics SA (SOPH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ... (GuruFocus.com)
May-06-25 07:55AM	SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:45AM	SOPHiA GENETICS Reports First Quarter 2025 Results (PR Newswire)
May-05-25 10:19AM	Earnings To Watch: Sophia Genetics SA (SOPH) Reports Q1 2025 Result (GuruFocus.com)
Apr-28-25 03:00PM	Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? (Zacks)
12:23PM	SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR (PR Newswire)
Apr-25-25 04:49AM	The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS (Zacks)
Apr-24-25 03:00PM	Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal? (Zacks)
Apr-22-25 08:00AM	SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025 (PR Newswire)
Apr-08-25 02:00AM	Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM Platform and its Liquid Biopsy Capabilities (PR Newswire)
Apr-01-25 03:00PM	Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? (Zacks)
Mar-21-25 12:00PM	SOPHiA GENETICS (SOPH) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-18-25 09:00AM	SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC (PR Newswire)
Mar-05-25 02:04AM	Sophia Genetics SA (SOPH) Q4 2024 Earnings Call Highlights: Record Customer Growth Amidst ... (GuruFocus.com)
Mar-04-25 07:55AM	SOPHiA GENETICS SA (SOPH) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -13.17%
06:45AM	SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results (PR Newswire)
Mar-03-25 07:21AM	What To Expect From Sophia Genetics SA (SOPH) Q4 2024 Earnings (GuruFocus.com)
Feb-24-25 04:03AM	Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy Testing (PR Newswire)
Feb-18-25 08:30AM	SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025 (PR Newswire) +11.22%
Jan-28-25 08:59AM	SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities (PR Newswire)
Nov-21-24 05:30AM	SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024 (PR Newswire)
Nov-06-24 06:59AM	SOPHiA GENETICS Faces Financial Challenges Amid Losses (TipRanks) -9.33%
02:08AM	Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
12:10AM	Q3 2024 Sophia Genetics SA Earnings Call (Thomson Reuters StreetEvents)
Nov-05-24 06:32AM	SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer (PR Newswire)
06:30AM	SOPHiA GENETICS Reports Third Quarter 2024 Results (PR Newswire)
Nov-04-24 09:57AM	SOPHiA GENETICS SA (SOPH): A Bull Case Theory (Insider Monkey)
07:13AM	Sophia Genetics SA (SOPH) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-22-24 06:45AM	SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024 (PR Newswire)
Sep-14-24 09:00AM	SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 (PR Newswire)
Sep-12-24 07:00AM	SOPHiA GENETICS Announces Poster Presentations at ESMO 2024 (PR Newswire)
04:00AM	SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024 (PR Newswire)
Sep-11-24 07:33AM	Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout (Medical Device Network) +8.70%
Sep-10-24 10:28AM	SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing (PR Newswire)
Sep-05-24 08:30AM	SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024 (PR Newswire) +5.59%
Sep-04-24 06:00AM	SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024 (PR Newswire)
Aug-28-24 01:30PM	SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference (PR Newswire) +5.26%
Aug-14-24 09:13AM	Sophia Genetics secures CE mark for DDM analytics platform under EUs IVDR (Medical Device Network)
03:00AM	SOPHiA DDM Platform Certified Under IVDR (PR Newswire)
Aug-12-24 09:35AM	SOPHiA GENETICS (SOPH) Loses -30.47% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Aug-09-24 12:00PM	What Makes SOPHiA GENETICS (SOPH) a New Buy Stock (Zacks)
Aug-06-24 07:55AM	SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:45AM	SOPHiA GENETICS Reports Second Quarter 2024 Results (PR Newswire)
Jul-29-24 10:30AM	SOPHiA GENETICS Announces L'hpital Universitaire Avicenne is Live on SOPHiA DDM (PR Newswire)
Jul-24-24 11:59AM	SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix (PR Newswire)
Jul-23-24 06:45AM	SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024 (PR Newswire)
Jul-05-24 04:32AM	Indias Dhiti Omics deploys SOPHiA DDM platform for solid tumour testing (Medical Device Network)
Jul-04-24 02:30AM	India-Based Dhiti Omics is Now Live on SOPHiA DDM (PR Newswire)
Jun-24-24 09:47AM	SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting (GlobeNewswire)
02:00AM	SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application (PR Newswire)
Jun-13-24 06:00AM	SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM Platform (PR Newswire)
May-30-24 12:39PM	SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care (PR Newswire)
May-29-24 10:00AM	SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities (PR Newswire)
May-20-24 10:02AM	SOPHiA GENETICS Announces Instituto Mrio Penna as New Customer (PR Newswire)
May-16-24 06:02AM	Klinikum Klagenfurt am Wrthersee is Live with SOPHiA GENETICS (PR Newswire)
May-13-24 12:22PM	SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 10:53AM	SOPH Stock Earnings: Sophia Genetics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:55AM	Wall Street Analysts Think SOPHiA GENETICS (SOPH) Could Surge 64.95%: Read This Before Placing a Bet (Zacks)
06:45AM	SOPHiA GENETICS Reports First Quarter 2024 Results (GlobeNewswire)
Apr-30-24 07:05AM	SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Apr-23-24 10:29AM	SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024 (GlobeNewswire)
06:37AM	Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering (MT Newswires)

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Menu Philippe	Chief Medical Officer	Apr 27 '26	Sale	4.82	5,000	24,089	261,388	Apr 28 04:03 PM
Valente Manuela	Chief People Officer	Apr 20 '26	Sale	5.20	380	1,977	215,071	Apr 21 04:04 PM
Xu Zhenyu	Chief Scientific Officer	Apr 20 '26	Sale	5.21	608	3,165	630,888	Apr 21 04:04 PM
Van Well Daan	Chief Legal Officer	Apr 20 '26	Sale	5.20	684	3,554	345,736	Apr 21 04:04 PM
Camblong Jurgi	Chief Executive Officer	Apr 20 '26	Sale	5.21	4,486	23,350	3,642,481	Apr 21 04:04 PM
Menu Philippe	Chief Medical Officer	Apr 20 '26	Sale	5.20	608	3,162	266,388	Apr 21 04:04 PM
Muken Ross	President	Apr 20 '26	Sale	5.20	760	3,955	681,672	Apr 21 04:04 PM
Puylaert Kevin	Chief Sales Officer	Apr 20 '26	Sale	5.08	33	168	148,197	Apr 21 04:04 PM
PHILIPPE MENU	Officer	Apr 20 '26	Proposed Sale	5.28	10,608	56,010		Apr 20 04:32 PM
JURGI CAMBLONG	Director	Apr 20 '26	Proposed Sale	5.28	12,986	68,566		Apr 20 04:32 PM
MANUELA VALENTE	Officer	Apr 20 '26	Proposed Sale	5.28	380	2,006		Apr 20 04:32 PM
ZHENYU XU	Officer	Apr 20 '26	Proposed Sale	5.28	4,608	24,330		Apr 20 04:32 PM
ROSS J MUKEN	Officer	Apr 20 '26	Proposed Sale	5.28	760	4,013		Apr 20 04:32 PM
DAAN GUIDO MARIA VAN WELL	Officer	Apr 20 '26	Proposed Sale	5.28	684	3,612		Apr 20 04:29 PM
Xu Zhenyu	Chief Scientific Officer	Apr 14 '26	Sale	4.97	600	2,980	631,496	Apr 16 04:03 PM
Camblong Jurgi	Chief Executive Officer	Apr 14 '26	Sale	4.96	43,129	213,834	3,664,440	Apr 16 04:03 PM
Camblong Jurgi	Chief Executive Officer	Apr 15 '26	Sale	5.00	17,473	87,402	3,646,967	Apr 16 04:03 PM
Menu Philippe	Chief Medical Officer	Apr 14 '26	Sale	4.96	1,600	7,933	266,996	Apr 16 04:03 PM
Muken Ross	President	Apr 14 '26	Sale	4.96	2,800	13,887	682,432	Apr 16 04:03 PM
Van Well Daan	Chief Legal Officer	Apr 10 '26	Sale	4.67	2,400	11,201	346,420	Apr 14 04:02 PM
Xu Zhenyu	Chief Scientific Officer	Apr 13 '26	Sale	4.76	4,414	21,027	632,096	Apr 14 04:02 PM
Xu Zhenyu	Chief Scientific Officer	Apr 10 '26	Sale	4.68	3,706	17,347	636,510	Apr 14 04:02 PM
Camblong Jurgi	Chief Executive Officer	Apr 10 '26	Sale	4.72	12,232	57,711	3,711,968	Apr 14 04:02 PM
Camblong Jurgi	Chief Executive Officer	Apr 13 '26	Sale	4.76	4,399	20,957	3,707,569	Apr 14 04:02 PM
Muken Ross	President	Apr 13 '26	Sale	4.76	4,442	21,166	685,232	Apr 14 04:02 PM
Muken Ross	President	Apr 10 '26	Sale	4.69	3,687	17,279	689,674	Apr 14 04:02 PM
Menu Philippe	Chief Medical Officer	Apr 13 '26	Sale	4.76	4,400	20,962	268,596	Apr 14 04:01 PM
Menu Philippe	Chief Medical Officer	Apr 10 '26	Sale	4.68	3,725	17,441	272,996	Apr 14 04:01 PM
Camblong Jurgi	Chief Executive Officer	Apr 08 '26	Sale	4.84	2,800	13,553	3,726,150	Apr 10 04:02 PM
Camblong Jurgi	Chief Executive Officer	Apr 09 '26	Sale	4.74	1,950	9,244	3,724,200	Apr 10 04:02 PM
Muken Ross	President	Apr 08 '26	Sale	4.84	2,786	13,488	695,311	Apr 10 04:02 PM
Muken Ross	President	Apr 09 '26	Sale	4.74	1,950	9,239	693,361	Apr 10 04:02 PM
Xu Zhenyu	Chief Scientific Officer	Apr 08 '26	Sale	4.84	2,800	13,549	642,152	Apr 10 04:02 PM
Xu Zhenyu	Chief Scientific Officer	Apr 09 '26	Sale	4.74	1,936	9,176	640,216	Apr 10 04:02 PM
Menu Philippe	Chief Medical Officer	Apr 08 '26	Sale	4.84	2,800	13,544	278,652	Apr 10 04:02 PM
Menu Philippe	Chief Medical Officer	Apr 09 '26	Sale	4.74	1,931	9,152	276,721	Apr 10 04:02 PM
Valente Manuela	Chief People Officer	Apr 08 '26	Sale	4.85	3,824	18,543	215,451	Apr 10 04:02 PM
Van Well Daan	Chief Legal Officer	Apr 08 '26	Sale	4.85	2,861	13,862	350,808	Apr 10 04:02 PM
Van Well Daan	Chief Legal Officer	Apr 09 '26	Sale	4.74	1,988	9,424	348,820	Apr 10 04:02 PM
CARDOZA GEORGE	Chief Financial Officer	Apr 08 '26	Sale	4.85	1,403	6,801	291,458	Apr 10 04:02 PM
GEORGE CARDOZA	Officer	Apr 08 '26	Proposed Sale	4.90	1	5		Apr 08 04:37 PM
Menu Philippe	Chief Medical Officer	Apr 06 '26	Sale	4.85	2,700	13,096	283,852	Apr 08 04:05 PM
Menu Philippe	Chief Medical Officer	Apr 07 '26	Sale	4.87	2,400	11,677	281,452	Apr 08 04:05 PM
Puylaert Kevin	Chief Sales Officer	Apr 06 '26	Sale	4.86	624	3,032	148,230	Apr 08 04:05 PM
Van Well Daan	Chief Legal Officer	Apr 06 '26	Sale	4.86	2,705	13,136	356,069	Apr 08 04:04 PM
Van Well Daan	Chief Legal Officer	Apr 07 '26	Sale	4.87	2,400	11,682	353,669	Apr 08 04:04 PM
Muken Ross	President	Apr 06 '26	Sale	4.85	2,600	12,603	700,521	Apr 08 04:04 PM
Muken Ross	President	Apr 07 '26	Sale	4.87	2,424	11,801	698,097	Apr 08 04:04 PM
Camblong Jurgi	Chief Executive Officer	Apr 06 '26	Sale	4.85	2,600	12,614	3,731,450	Apr 08 04:04 PM
Camblong Jurgi	Chief Executive Officer	Apr 07 '26	Sale	4.86	2,500	12,155	3,728,950	Apr 08 04:04 PM
CARDOZA GEORGE	Chief Financial Officer	Apr 06 '26	Sale	4.85	2,520	12,211	295,274	Apr 08 04:04 PM
CARDOZA GEORGE	Chief Financial Officer	Apr 07 '26	Sale	4.88	2,413	11,768	292,861	Apr 08 04:04 PM
Valente Manuela	Chief People Officer	Apr 06 '26	Sale	4.85	2,597	12,583	221,651	Apr 08 04:04 PM
Valente Manuela	Chief People Officer	Apr 07 '26	Sale	4.87	2,376	11,566	219,275	Apr 08 04:04 PM
Xu Zhenyu	Chief Scientific Officer	Apr 06 '26	Sale	4.85	2,700	13,100	647,352	Apr 08 04:04 PM
Xu Zhenyu	Chief Scientific Officer	Apr 07 '26	Sale	4.87	2,400	11,679	644,952	Apr 08 04:04 PM
Verma Abhimanyu	Chief Technology Officer	Apr 06 '26	Sale	4.86	2,519	12,240	205,430	Apr 08 04:04 PM
Verma Abhimanyu	Chief Technology Officer	Apr 07 '26	Sale	4.87	1,030	5,016	204,400	Apr 08 04:04 PM
ROSS J MUKEN	Officer	Apr 06 '26	Proposed Sale	5.04	20,689	104,273		Apr 06 04:33 PM
DAAN GUIDO MARIA VAN WELL	Officer	Apr 06 '26	Proposed Sale	5.04	12,354	62,264		Apr 06 04:32 PM
ZHENYU XU	Officer	Apr 06 '26	Proposed Sale	5.04	18,556	93,522		Apr 06 04:32 PM
GEORGE CARDOZA	Officer	Apr 06 '26	Proposed Sale	5.04	6,335	31,928		Apr 06 04:31 PM
PHILIPPE MENU	Officer	Apr 06 '26	Proposed Sale	5.04	19,556	98,562		Apr 06 04:31 PM
MANUELA VALENTE	Officer	Apr 06 '26	Proposed Sale	5.04	8,797	44,337		Apr 06 04:31 PM
JURGI CAMBLONG	Director	Apr 06 '26	Proposed Sale	5.04	87,083	438,898		Apr 06 04:31 PM
Puylaert Kevin	Chief Sales Officer	Mar 31 '26	Sale	4.71	3	14	92,383	Apr 01 10:41 AM
Van Well Daan	Chief Legal Officer	Mar 19 '26	Sale	4.79	684	3,274	261,238	Mar 20 04:01 PM
Camblong Jurgi	Chief Executive Officer	Mar 19 '26	Sale	4.77	4,486	21,410	3,302,839	Mar 20 04:01 PM
Menu Philippe	Chief Medical Officer	Mar 19 '26	Sale	4.79	608	2,913	173,616	Mar 20 04:01 PM
Xu Zhenyu	Chief Scientific Officer	Mar 19 '26	Sale	4.78	608	2,907	537,116	Mar 20 04:01 PM
Valente Manuela	Chief People Officer	Mar 19 '26	Sale	4.79	380	1,818	152,379	Mar 20 04:01 PM
Muken Ross	President	Mar 19 '26	Sale	4.79	1,183	5,671	271,910	Mar 20 04:01 PM
Puylaert Kevin	Chief Sales Officer	Mar 19 '26	Sale	4.76	33	157	92,386	Mar 20 04:01 PM
CARDOZA GEORGE	Chief Financial Officer	Mar 19 '26	Sale	4.79	774	3,705	184,858	Mar 20 04:00 PM
ZHENYU XU	Officer	Mar 19 '26	Proposed Sale	4.91	608	2,985		Mar 19 04:25 PM
DAAN GUIDO MARIA VAN WELL	Officer	Mar 19 '26	Proposed Sale	4.91	684	3,358		Mar 19 04:25 PM
ROSS J MUKEN	Officer	Mar 19 '26	Proposed Sale	4.91	1,183	5,809		Mar 19 04:23 PM
GEORGE CARDOZA	Officer	Mar 19 '26	Proposed Sale	4.91	774	3,800		Mar 19 04:23 PM
PHILIPPE MENU	Officer	Mar 19 '26	Proposed Sale	4.91	608	2,985		Mar 19 04:22 PM
MANUELA VALENTE	Officer	Mar 19 '26	Proposed Sale	4.91	380	1,866		Mar 19 04:22 PM
JURGI CAMBLONG	Director	Mar 19 '26	Proposed Sale	4.91	4,486	22,026		Mar 19 04:22 PM
JURGI CAMBLONG	Director	Mar 16 '26	Proposed Sale	4.61	1,984	9,146		Mar 16 04:40 PM
KATHY L HIBBS	Director	Mar 10 '26	Proposed Sale	4.46	15,508	69,166		Mar 10 04:38 PM
ZHENYU XU	Officer	Feb 19 '26	Proposed Sale	4.83	4,608	22,257		Feb 19 04:26 PM
DAAN GUIDO MARIA VAN WELL	Officer	Feb 19 '26	Proposed Sale	4.83	684	3,304		Feb 19 04:26 PM
ROSS J MUKEN	Officer	Feb 19 '26	Proposed Sale	4.83	760	3,671		Feb 19 04:25 PM
PHILIPPE MENU	Officer	Feb 19 '26	Proposed Sale	4.83	5,608	27,087		Feb 19 04:25 PM
MANUELA VALENTE	Officer	Feb 19 '26	Proposed Sale	4.83	380	1,835		Feb 19 04:25 PM
JURGI CAMBLONG	Director	Jan 22 '26	Proposed Sale	5.42	57,001	308,945		Jan 22 04:34 PM
JURGI CAMBLONG	Director	Jan 20 '26	Proposed Sale	5.45	7,485	40,793		Jan 20 04:39 PM
ROSS J MUKEN	Officer	Jan 20 '26	Proposed Sale	5.45	760	4,142		Jan 20 04:38 PM
ZHENYU XU	Officer	Jan 20 '26	Proposed Sale	5.45	4,608	25,114		Jan 20 04:36 PM
PHILIPPE MENU	Officer	Jan 20 '26	Proposed Sale	5.45	5,608	30,564		Jan 20 04:27 PM
DAAN GUIDO MARIA VAN WELL	Officer	Jan 20 '26	Proposed Sale	5.45	684	3,728		Jan 20 04:25 PM
MANUELA VALENTE	Officer	Jan 20 '26	Proposed Sale	5.45	380	2,071		Jan 20 04:25 PM
JURGI CAMBLONG	Director	Jan 16 '26	Proposed Sale	5.16	30,959	159,748		Jan 16 04:24 PM
JURGI CAMBLONG	Director	Jan 09 '26	Proposed Sale	4.96	117,541	583,003		Jan 09 04:30 PM
JURGI CAMBLONG	Director	Jan 07 '26	Proposed Sale	4.80	30,000	144,000		Jan 07 04:36 PM
PHILIPPE MENU	Officer	Jan 06 '26	Proposed Sale	4.60	10,006	46,028		Jan 06 04:33 PM
ZHENYU XU	Officer	Jan 05 '26	Proposed Sale	4.67	9,006	42,058		Jan 05 04:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SOPH

SOPHiA Genetics SA

Upgrade your Finviz experience